- Living donor liver transplantation for Wilson disease: A collective review
-
Park JI, Chung YK
- KMID: 2560926
- Ann Liver Transplant.
- 2023 Nov;3(2):73-79.
- doi: 10.52604/alt.23.0020
Wilson disease (WD) is a recognized metabolic disorder characterized by abnormal copper accumulation and excretion in the human body. The liver-related symptoms may range from acute liver failure to chronic... -
- CITED
-
- Close
- SHARE
-
- Close
- ADV score is a reliable surrogate biomarker of hepatocellular carcinoma in liver resection and transplantation
-
Hwang S, Jung DH, Song GW
- KMID: 2560928
- Ann Liver Transplant.
- 2023 Nov;3(2):86-93.
- doi: 10.52604/alt.23.0023
A composite score, known as the ADV score, which is calculated by multiplying the levels of α-fetoprotein and des-γ-carboxy prothrombin along with tumor volume, has been demonstrated as an all-encompassing prognostic indicator... -
- CITED
-
- Close
- SHARE
-
- Close
- Pediatric liver transplantation for Wilson disease
-
Park JI, Jung BH
- KMID: 2560927
- Ann Liver Transplant.
- 2023 Nov;3(2):80-85.
- doi: 10.52604/alt.23.0019
Wilson disease (WD) stands as an autosomal recessive disorder primarily brought about by genetic mutations affecting the ATP7B gene, yielding a prevalence rate estimated at 1:30,000 to 50,000 individuals. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of living donors in liver transplantation in a low volume center
-
Chang SH
- KMID: 2560930
- Ann Liver Transplant.
- 2023 Nov;3(2):100-103.
- doi: 10.52604/alt.23.0018
Background: Living donor liver transplantation (LDLT) is an unavoidable procedure due to shortage of deceased donors. Since the first successful LDLT, many reports have shown excellent outcomes, but the safety... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-term weight reduction program in potential donors with severe steatosis can reduce liver volume significantly that changes clinical decision in living donor transplantation
-
Kim Y, Lee KW, Choi Y, Hong Sy, Yi NJ, Hong SK, Lee JM, Suh KS
- KMID: 2560932
- Ann Liver Transplant.
- 2023 Nov;3(2):113-117.
- doi: 10.52604/alt.23.0014
Short-term weight reduction (SWR) programs have been demonstrated to ameliorate liver steatosis, transforming marginal donors into viable candidates for living donor liver transplantation (LDLT). These interventions impact objective indices of... -
- CITED
-
- Close
- SHARE
-
- Close
- Biological immunosuppressive agents used in liver transplantation
-
Park CS, Chung YK
- KMID: 2560924
- Ann Liver Transplant.
- 2023 Nov;3(2):63-68.
- doi: 10.52604/alt.23.0021
Liver transplantation (LT) has become the preferred treatment for conditions like end-stage liver failure and hepatocellular carcinoma. With advancements in immunosuppressive therapies over time, there have been significant improvements in... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver transplantation for giant hepatic hemangioma: A collective review
-
Park CS, Chung YK
- KMID: 2560925
- Ann Liver Transplant.
- 2023 Nov;3(2):69-72.
- doi: 10.52604/alt.23.0017
Giant hepatic hemangiomas (HHs) have been often considered benign, but their huge size and potential complications can make them far from benign in their impact on the lives. Amid the... -
- CITED
-
- Close
- SHARE
-
- Close
- Living donor liver transplantation with direct collateral portal vein anastomosis in a pediatric patient with congenital absence of the portal vein
-
Namgoong JM, Hwang S, Park GC, Lee DY, Kim KM, Oh SH
- KMID: 2560934
- Ann Liver Transplant.
- 2023 Nov;3(2):128-135.
- doi: 10.52604/alt.23.0013
Congenital absence of the portal vein (CAPV) is a rare venous malformation in which the mesenteric venous blood drains directly into the systemic circulation. We report a case of pediatric... -
- CITED
-
- Close
- SHARE
-
- Close
- Living donor liver transplantation with pericholedochal collateral vein anastomosis in a pediatric patient with congenital absence of the portal vein
-
Namgoong JM, Hwang S, Park GC, Kang S, Kim KM, Oh SH
- KMID: 2560933
- Ann Liver Transplant.
- 2023 Nov;3(2):118-127.
- doi: 10.52604/alt.23.0016
Congenital absence of the portal vein (CAPV) is a rare venous malformation in which the mesenteric venous blood drains directly into the systemic circulation. We report a case of pediatric... -
- CITED
-
- Close
- SHARE
-
- Close
- Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve prognosis
-
Kwon J, Kim J, Rhu J, Choi GS, Joh JW
- KMID: 2560931
- Ann Liver Transplant.
- 2023 Nov;3(2):104-112.
- doi: 10.52604/alt.23.0022
Background: Systemic treatment options for hepatocellular carcinoma (HCC) after liver transplantation (LT) are limited in patients in whom sorafenib treatment was failed. The purpose of our study was to compare... -
- CITED
-
- Close
- SHARE
-
- Close
- Analyzing bench-surgery time: A comparative study of pure laparoscopic and open left hepatectomy including the middle hepatic vein in living liver donors
-
Hong SK, Kim M, Kim Y, Kim JY, Lee J, Kim J, Hong Sy, Lee JM, Choi Y, Yi NJ, Lee KW, Suh KS
- KMID: 2560929
- Ann Liver Transplant.
- 2023 Nov;3(2):94-99.
- doi: 10.52604/alt.23.0015
Background: Pure laparoscopic donor hepatectomy (PLDH) has garnered attention due to its potential advantages in donor cosmesis and functional outcomes. This study focuses on bench-surgery in pure laparoscopic donor left... -
- CITED
-
- Close
- SHARE
-
- Close
